{"id":163350,"date":"2022-09-24T01:59:54","date_gmt":"2022-09-24T05:59:54","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/oncternal-therapeutics-to-participate-in-the-cantor-oncology-hematology-hemeonc-conference\/"},"modified":"2024-08-18T11:46:03","modified_gmt":"2024-08-18T15:46:03","slug":"oncternal-therapeutics-to-participate-in-the-cantor-oncology-hematology-hemeonc-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/oncternal-therapeutics-to-participate-in-the-cantor-oncology-hematology-hemeonc-conference.php","title":{"rendered":"Oncternal Therapeutics to Participate in the Cantor Oncology, Hematology &amp; HemeOnc Conference"},"content":{"rendered":"<p><![CDATA[SAN DIEGO, Sept.  23, 2022  (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that management will participate in the Cantor Oncology, Hematology & HemeOnc Conference on Wednesday, September 28, 2022 at the NY Palace Hotel in New York City.]]><\/p>\n<p>Read the original here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/09\/23\/2521811\/0\/en\/Oncternal-Therapeutics-to-Participate-in-the-Cantor-Oncology-Hematology-HemeOnc-Conference.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Oncternal Therapeutics to Participate in the Cantor Oncology, Hematology &amp; HemeOnc Conference\">Oncternal Therapeutics to Participate in the Cantor Oncology, Hematology &amp; HemeOnc Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the original here: Oncternal Therapeutics to Participate in the Cantor Oncology, Hematology &amp; HemeOnc Conference <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/oncternal-therapeutics-to-participate-in-the-cantor-oncology-hematology-hemeonc-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-163350","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163350"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=163350"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163350\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=163350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=163350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=163350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}